Investors Buy Shares of UnitedHealth Group Incorporated (UNH) on Weakness

Investors bought shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading hours on Tuesday. $115.67 million flowed into the stock on the tick-up and $90.63 million flowed out of the stock on the tick-down, for a money net flow of $25.04 million into the stock. Of all equities tracked, UnitedHealth Group had the 19th highest net in-flow for the day. UnitedHealth Group traded down ($1.62) for the day and closed at $194.68

Several analysts have recently weighed in on the stock. Barclays PLC increased their price target on shares of UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a research note on Wednesday, July 19th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday, September 21st. Cowen and Company reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Friday, July 14th. Jefferies Group LLC reaffirmed a “buy” rating and set a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 18th. Finally, BidaskClub cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $203.59.

The company’s 50-day moving average price is $196.60 and its 200-day moving average price is $184.31. The firm has a market cap of $188.79 billion, a P/E ratio of 23.46 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter last year, the company earned $1.96 EPS. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were issued a $0.75 dividend. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.

In related news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last ninety days, insiders sold 76,174 shares of company stock worth $14,981,909. Corporate insiders own 0.89% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Blue Chip Partners Inc. bought a new position in UnitedHealth Group in the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $114,000. Patriot Financial Group Insurance Agency LLC grew its position in UnitedHealth Group by 1,722.9% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares in the last quarter. Finally, BDO Wealth Advisors LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $121,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://sportsperspectives.com/2017/10/12/investors-buy-shares-of-unitedhealth-group-incorporated-unh-on-weakness.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply